Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Expanded vaccination and treatment could help eliminate hepatitis B worldwide

While universal infant hepatitis B virus (HBV) vaccination has already led to major advances in reducing new infections in some settings, further expansion of prevention and treatment

Published
25 April 2015
By
Liz Highleyman
Cancer drug shows promise as cure for hepatitis B

A potential cure for hepatitis B virus infections has been found with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models. Australian patients are now the first in the world to have access to the potential treatment -- a combination of an antiviral drug and an anti-cancer drug -- which is in phase 1/2a clinical trials.

Published
21 April 2015
From
Science Daily
Arrowhead initiates phase 2b trial for potential HBV drug

After receiving a clinical hold from the FDA earlier this year, Arrowhead Research Corporation has now been approved by the FDA to begin a multiple-dose phase 2b clinical study of ARC-520 for the treatment of chronic hepatitis B infection, according to a news release from the drug maker.

Published
14 April 2015
From
Healio Hepatology
Global hepatitis B epidemic treatable at cost of just $36 per patient per year

Large-scale production of generic entecavir could cut the cost of first-line hepatitis B virus (HBV) therapy to just US$36 per patient per year, according to a study published

Published
08 April 2015
By
Michael Carter
Oral hepatitis B vaccine could become a reality

In a new study, researchers report progress toward perfecting a radical new method of producing vaccines using genetically modified corn. The approach could lead to an oral hepatitis B vaccine that requires no refrigeration and costs less than $1 per dose to manufacture.

Published
01 April 2015
From
Medical Xpress
WHO issues its first hepatitis B treatment guidelines

WHO today issued its first-ever guidance for the treatment of chronic hepatitis B, a viral infection which is spread through blood and body fluids, attacking the liver and resulting in an estimated 650 000 deaths each year – most of them in low- and middle-income countries.

Published
12 March 2015
From
World Health Organization
Hepatitis Quest Moves From C to B Under Former Gilead Executives

Gilead Sciences Inc. raked in $10 billion last year with its Sovaldi pill for hepatitis C. Many of the people responsible for the drug are now competing to repeat that success for a more common liver disease: hepatitis B.

Published
05 February 2015
From
Bloomberg
Experimental siRNA therapy lowers HBsAg levels in people with hepatitis B

ARC-520, a novel therapy using short interfering RNA, appeared safe and was associated with a reduction in hepatitis B surface antigen levels in people with chronic hepatitis

Published
06 January 2015
By
Liz Highleyman
New open-access journal in the rapidly developing field of virus eradication

The Journal of Virus Eradication is a new open-access online and print journal dedicated to the rapidly developing field of virus eradication. It is particularly interested in publishing original research on HIV, hepatitis viruses, HPV, herpes and flu but work on other viruses is also included. The first issue was successfully launched at the HIV and Hepatitis Five Nations Conference in London on 8 December 2014 and is available now on the Journal website: www.viruseradication.com

Published
23 December 2014
From
Mediscript
Entecavir and tenofovir work well for people with drug-resistant hepatitis B virus

A combination of entecavir plus tenofovir effectively suppressed hepatitis B virus (HBV) in people with resistance to other antivirals, according to results from the European ENTEBE study

Published
22 December 2014
By
Liz Highleyman
← First12345...12Next →

Filter by country